Inhibition of NF-κB Signaling in Cryptosporidium parvum Infection
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Creighton University
Other organizations : University of California, Los Angeles, Cedars-Sinai Medical Center
Variable analysis
- SC-514 (100 μM, Calbiochem), a potent IKK-2 inhibitor
- JSH-23 (Santa Cruz Biotechnology, Dallas, TX), a cell-permeable, selective inhibitor of nuclear translocation of NF-кB p65 and its transcription activity
- CpG-ODN 1668 (TCCATGACGTTCCTGATGCT)
- Lipopolysaccharide (LPS, from E. coli strain K12)
- IFN-γ
- TNF-α
- Not explicitly mentioned
- Murine intestinal epithelial cell line (IEC4.1)
- MuINTEPI, a murine intestinal epithelial cell line
- Lipopolysaccharide (LPS, from E. coli strain K12)
- IFN-γ
- TNF-α
- SC-514, TNF-α, IFN-γ and LPS at the utilized concentrations showed no cytotoxic effects on IEC4.1 and muINTEPI cells
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!